Clinical trial
SAFE: Surveillance And Follow-up Evaluation of FemBloc
NCT07924293 is registered in ClinicalTrials.gov with Femasys Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- SAFE: Surveillance And Follow-up Evaluation of FemBloc
- Lead sponsor
- Femasys Inc.
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- October 22, 2025
- Completion date
- July 31, 2027
- Enrollment
- 200 (estimated)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
contraception
Arms
As registered; 1 arm.
-
FemBloc
Device
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Degree of patient satisfaction
To evaluate the acceptance of the FemBloc procedure in real life by female candidates by measuring the degree of satisfaction reported by participants on Likert scale (1-5, 5=highest satisfaction)
Lead sponsor's other trials
Femasys Inc., most recent start first.
+1 more trial